Hamamatsu Partners with Definiens to offer a#complete and fully integrated image analysis#solution

Munich, Germany – October 15, 2008 – Definiens, the number one Enterprise Image Intelligence™ company, and Hamamatsu, a world-leading manufacturer of devices for the generation and measurement of infrared, visible, and ultraviolet light, today signed a partner agreement for the European market.

Under the terms of the sales and marketing agreement, Hamamatsu and Definiens will integrate Definiens image analysis platforms - Definiens Enterprise Image Intelligence Suite™ and Definiens XD including Definiens TissueMap - with Hamamatsu’s NanoZoomer® Digital Pathology system (NDP®), a product suite for virtual microscopy. The NanoZoomer® scans tissue or cellular slides at remarkable speed and generates digital images with very high image quality. It creates digital slides which can be shared and viewed over a network. Definiens comprehensive image analysis platforms extract context-based information from any digital image in any dimension – be it 2D, 3D or 4D.

Definiens image analysis platforms are a perfect match to Hamamatsu’s state-of-the-art NanoZoomer®. The partnership will generate additional value for customers by integrating a sophisticated tissue slide scanner, capable of high throughput, sensitivity and resolution with a unique image analysis technology that emulates human cognitive processes to automatically extract intelligence from digital images.

Life science and crop science research institutes as well as the pharmaceutical industry will benefit from a complete and fully integrated image analysis solution, which is closing the loop from high-end image acquisition to high-content and high-throughput image analysis.

“By partnering with Hamamatsu we can provide our joint customers with a complete image analysis solution, which enables them to automate image analysis processes, reduce costs and make qualified decisions faster", says Manfred Voglmaier, Vice President Business Development Life Sciences at Definiens.

“Hamamatsu’s NanoZoomer is a high-throughput slide scanning system with superb image quality that - in combination with Definiens powerful image analysis software - enables histologists, pharmacologists and pathologists to get more reliable and reproducible image analysis results”, adds Dr. Erk Mennenga-Klopp, Head of the Medical Solutions Department at Hamamatsu, Germany.

Both companies will offer active marketing and sales support including training and consultancy. In addition Definiens will provide application specialists and specific algorithms (rule set) development for Hamamatsu’s customer base.

About Hamamatsu

Hamamatsu Photonics is a world-leading manufacturer of opto-electronic components and systems and employs over 3000 staff worldwide. The corporate headquarters are based in Hamamatsu City, Japan along with six manufacturing plants and central research laboratories. Since its inception in 1953, Hamamatsu Photonics has expanded to now enjoy a global presence with production facilities, business locations and associated companies throughout Asia, Europe and North America.
Hamamatsu Photonics’ corporate philosophy stresses the advancement of Photonics through extensive research and development. The component- and system-products such as photosensors, cameras, complex systems are widely used in different research fields like communication, biomedical science, material science, pharmacology, medical science and many others.

Definiens in Life Sciences

By automating image analysis on an enterprise level, Definiens supports Life Science organizations to analyze and interpret vast numbers of images accurately and consistently. Definiens improves the measurement of cell assays, the examination of tissue samples and the interpretation of non-invasive imaging, enabling high-content screening, digital pathology and translational medicine.

About Definiens

Definiens is the number one Enterprise Image Intelligence company for analyzing and interpreting images on every scale, from microscopic cell structures to satellite images. The Definiens Cognition Network Technology®, developed by Nobel laureate Prof. Gerd Binnig and his team, is an advanced and robust context-based technology designed to fulfill the image analysis requirements of the Life and Earth sciences markets. The technology is modelled on the powerful human cognitive perception processes to extract intelligence from images. Definiens provides organizations with faster image analysis results, allowing deeper insights enabling better business decisions. The company is headquartered in Munich, Germany and has offices throughout the United States. Further information is available at www.definiens.com.

Definiens, Definiens Cellenger, Definiens Cognition Network Technology, Definiens eCognition, Enterprise Image Intelligence and Understanding Images are trademarks or registered trademarks of Definiens.

Press contacts